Literature DB >> 2758737

A longitudinal study of multimodal evoked potentials in diabetes mellitus.

G Pozzessere1, P A Rizzo, E Valle, M A Mollica, L Sanarelli, S Morano, P Pietravalle, U Di Mario, C Morocutti.   

Abstract

Abnormal findings in visual (VEP), brainstem auditory (BAEP) and somatosensory (SEP) evoked potentials at early stages of Type 1 and Type 2 diabetes have recently been reported by our group. Our aim here was to perform a longitudinal study in diabetic patients at an early stage of the disease using a combined evoked potential analysis in order to evaluate the variation of neurological abnormalities over time. Nine Type 1 and 12 Type 2 diabetic patients were examined and a second recording was carried out after a mean interval of 15.7 months +/- 6.2 SD. VEP, BAEP and SEP were measured in all patients. At the first recording electrophysiological abnormalities, present in both Type 1 and Type 2 diabetes were more evident when a multimodal evaluation was used (44.4% and 66.7% respectively). The follow-up study showed that overall neurological abnormalities persisted in all those patients who had previously presented pathological values. Whereas the number of patients with pathological values remained unmodified, a tendency to progression, namely the number of nervous levels with electrophysiological abnormalities, was observed. Thus, our study confirms the appearance of anatomofunctional disorders in the central nervous system in short-term diabetes, shows the persistence of neurological impairment in such patients and reveals a progressive segmental involvement at different nervous levels.

Entities:  

Mesh:

Year:  1989        PMID: 2758737

Source DB:  PubMed          Journal:  Diabetes Res        ISSN: 0265-5985


  8 in total

1.  Visual evoked potentials after photostress in newly diagnosed insulin-dependent diabetes patients.

Authors:  V Parisi; L Uccioli; G Monticone; L Parisi; L Durola; C Pernini; R Neuschuler; G Menzinger; M G Bucci
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-10       Impact factor: 3.117

2.  Impact of continuous vs. interval training on oxygen extraction and cardiac function during exercise in type 2 diabetes mellitus.

Authors:  Lisa Van Ryckeghem; Charly Keytsman; Jana De Brandt; Kenneth Verboven; Elvire Verbaanderd; Nastasia Marinus; Wouter M A Franssen; Ines Frederix; Elise Bakelants; Thibault Petit; Siddharth Jogani; Sarah Stroobants; Paul Dendale; Virginie Bito; Jan Verwerft; Dominique Hansen
Journal:  Eur J Appl Physiol       Date:  2022-01-17       Impact factor: 3.078

3.  Visual evoked potentials after photostress in insulin-dependent diabetic patients with or without retinopathy.

Authors:  V Parisi; L Uccioli; G Monticone; L Parisi; G Menzinger; M G Bucci
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-04       Impact factor: 3.117

4.  Effects of hyperglycaemia on visual evoked potentials in insulin-dependent diabetic patients.

Authors:  V Martinelli; P M Piatti; M Filippi; M Pacchioni; M R Pastore; N Canal; G Comi
Journal:  Acta Diabetol       Date:  1992       Impact factor: 4.280

5.  Electrophysiological assessment of visual function in newly-diagnosed IDDM patients.

Authors:  L Uccioli; V Parisi; G Monticone; L Parisi; L Durola; C Pernini; R Neuschuler; M G Bucci; G Menzinger
Journal:  Diabetologia       Date:  1995-07       Impact factor: 10.122

6.  Tibial nerve somatosensory evoked potentials at various stages of peripheral neuropathy in insulin dependent diabetic patients.

Authors:  D Ziegler; H Mühlen; K Dannehl; F A Gries
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-01       Impact factor: 10.154

7.  Visual evoked potentials in NIDDM: a longitudinal study.

Authors:  G Moreo; E Mariani; G Pizzamiglio; G B Colucci
Journal:  Diabetologia       Date:  1995-05       Impact factor: 10.122

Review 8.  Clinical electrophysiology of the optic nerve and retinal ganglion cells.

Authors:  Oliver R Marmoy; Suresh Viswanathan
Journal:  Eye (Lond)       Date:  2021-06-11       Impact factor: 3.775

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.